Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, lab study reveals

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, a new study in the laboratory reveals.

from Top Health News -- ScienceDaily https://ift.tt/3jsPYWR